Genius
Genius GmbH (Ltd) is a PR firm based in Germany[1]. The company is described on its website as "a communicator between the field of science and the society".[2]
Genius was founded in 1998 as a spin-off of the Technical University Darmstadt. Shareholders are Kristina Sinemus, Klaus Minol, Hans Günter Gassen und Mogg. Kristina Sinemus is CEO, Klaus Minol Scientific Head.
Contents
Participation in research projects
Genius not only conceptualizes and designs print and online publications, but also provides content for them and develops some of this content through the active participation in German and EU projects. Genius describes itself as a “facilitator of transparency and communication” (Vermittler von Transparenz und Kommunikation), but the PR and consultancy company has a clear position in favour of genetic engineering.
The website (www.gmosafety.eu) is organised by a project network of Genius, Transgen and TÜV Nord. The website is financed by the German Ministry for Education and Research (BMBF) and publishes the results of BMBF projects and additional information on genetic engineering. It is also supported by the EU projects BIOSAFENET (Joachim Schiemann and ISBR. Klaus Minol is the contact person for BIOSAFENET and the results of this project are published on gmosafety.eu.
The website www.gmo-compass.org is also maintained by Genius and Transgen.
Kristina Sinemus and Klaus Minol represent Genius in the EU project CO-EXTRA as members of the management board, executive committee, as head of a working group and as editorial office.
Kristina Sinemus represents Genius in the EU Technology Platform Plants for the Future.
Participation in lobby organisations
Kristina Sinemus is member of the website committee of ISBR. The company Genius is member of BIO Germany and of the EFB.
Funding and clients
Genius has a wide range of clients from the German and European business sector and governments.[3]
Clients as at January 2011 include the German Ministry for education and research (BMBF), German Ministry for food, agriculture and consumer protection (BVL), the European Commission, the European Food Safety Authority (EFSA); the biotechnology and agrochemical companies BASF AG, BASF Plant Science, Bayer AG, DuPont, Syngenta, and Novartis; pharma firm Pfizer Animal Health; the public-private plant breeding organisation InnoPlanta e.V.; and the public-private partnership Science4Life.[4]
Genius has edited EFSA's publications, including its annual report 2006.
Website
www.genius.de
Funding
Contact
- Address:
- ...
- ...
- ...
- ...
- Phone:
- ...
- Email:
- ...
- Website:
- ...
